stockrow
Friday 6 November 2026
Export ENOV’s income statement to Excel — free account
Enovis Corporation
ENOV Healthcare Medical Devices
Enovis Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, up 6.66% from fiscal 2024.
- Revenue
- +1.79%
- EPS
- +100.6%
- Free cash flow
- +20.3%
- Total debt
- −7.45%
Quarter to September 2026, against a year earlier
27.07
1.55
−5.42%
Follow ENOV
Alert me
Enovis Corporation (ENOV) P/E ratio
Enovis Corporation has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 161× (March 2021) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 95.8× | (22.36%) |
| FY2020 | 123× | — |
| FY2019 | 0.0× | — |
| FY2018 | 17.9× | (45.27%) |
| FY2017 | 32.6× | (8.00%) |
| FY2016 | 35.5× | 260.18% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 0.0× | — |
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| 43 more quarters | Free account |
Against its own ten years
Low 0.0×
High 161×
Ten-year median
9.3×
Current reading's percentile
45
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| AORT Artivion, Inc. compare | n/m |
| NVCR NovoCure Limited compare | n/m |
| LMRI Lumexa Imaging Holdings, Inc. compare | n/m |
| ENOV Enovis Corporation | n/m |
| TNDM Tandem Diabetes Care, Inc. compare | n/m |
| ATEC Alphatec Holdings, Inc. compare | n/m |
| PRCT PROCEPT BioRobotics Corporation compare | n/m |
| CNMD CONMED Corporation compare | 21.7× |
| IART Integra LifeSciences Holdings Corporation compare | 83.0× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)